Who owns Recursion Pharmaceuticals Inc (RXRX)? Superinvestor holders
2 superinvestors of the 157 tracked here hold Recursion Pharmaceuticals Inc (RXRX) in their latest 13F filing, with $259.9M between them. Cathie Wood gives it the most weight: 1.06% of the reported portfolio. In their latest reported quarter, Cathie Wood added; Baillie Gifford team reduced.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Cathie Wood, $184.8M
- Largest weight
- Cathie Wood, 1.06%of their portfolio
- Combined value
- $259.9M
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Cathie WoodARK Invest | 1.06% | $184.8M | 44.75M | ▲ Added 8.2% | +3.41M | Q3 2026 |
| 2 | Baillie Gifford teamBaillie Gifford & Co | 0.07% | $75.1M | 18.17M | ▼ Reduced 23% | −5.31M | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 62.92M | $259.9M | 1 | 1 |
| Q2 2026 | 157 | 2 | 64.83M | $237.9M | 1 | 1 |
| Q1 2026 | 157 | 2 | 63.89M | $196.1M | 1 | 1 |
| Q4 2025 | 157 | 2 | 61.09M | $249.9M | 1 | 1 |
| Q3 2025 | 157 | 2 | 57.52M | $280.7M | 1 | 1 |
| Q2 2025 | 157 | 2 | 57.16M | $289.2M | 0 | 2 |
| Q1 2025 | 156 | 2 | 59.21M | $313.2M | 1 | 2 |
| Q4 2024 | 156 | 3 | 64.94M | $439M | 0 | 3 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Cathie Wood | 44.75M | 41.34M | 40.21M | 37.32M | 33.55M | 32.99M | 34.82M | 32.35M |
| Baillie Gifford team | 18.17M | 23.49M | 23.68M | 23.77M | 23.98M | 24.17M | 24.39M | 24.86M |
| Peter Kolchinsky | · | — | — | — | — | — | — | 7.73M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own RXRX?
In their latest 13F filings: Cathie Wood (1.06% of the portfolio, $184.8M), Baillie Gifford team (0.07% of the portfolio, $75.1M).
Who bought RXRX last quarter?
Cathie Wood (added 8.2%). “Last quarter” is each investor's latest reported quarter.
Who sold RXRX last quarter?
Reduced: Baillie Gifford team (23% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Recursion Pharmaceuticals Inc (RXRX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/RXRX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to RXRX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.